Antibacterial and anticancer activity of two NK-lysin-derived peptides from the Antarctic teleost Trematomus bernacchii

Buonocore; F; Saraceni; P.R.; Taddei; A.R.; Miccoli; A; Porcelli; F; Borocci; S; Gerdol; M.; Bugli; F.; Sanguinetti; M.; Fausto; A.M.; Scapigliati; G.; Picchietti; S.;

The NK-lysin antimicrobial peptide, first identified in mammals, possesses both antibacterial and cytotoxic activity against cancer cell lines. Homologue peptides isolated from different fish species have been examined for their functional characteristics in the last few years. In this study, a NK-lysin transcript was identified in silico from the head kidney transcriptome of the Antarctic teleost Trematomus bernacchii. The corresponding amino acid sequence, slightly longer than NK-lysins of other fish species, contains six cysteine residues that in mammalian counterparts form three disulphide bridges. Real time-PCR analysis indicated its predominant expression in T. bernacchii immune-related organs and tissues, with greatest mRNA abundance detected in gills and spleen. Instead of focusing on the full T. bernacchii derived NK-lysin mature molecule, we selected a 27 amino acid residue peptide (named NKL-WT), corresponding to the potent antibiotic NK-2 sequence found in human NK-lysin. Moreover, we designed a mutant peptide (named NKL-MUT) in which two alanine residues substitute the two cysteines found in the NKL-WT. The two peptides were obtained by solid phase organic synthesis to investigate their functional features. NKL-WT and NKL-MUT displayed antibacterial activity against the human pathogenic bacterium Enterococcus faecalis and the ESKAPE pathogen Acinetobacter baumannii, respectively. Moreover, at the determined Minimum Inhibitory Concentration and Minimum Bactericidal Concentration values against these pathogens, both peptides showed high selectivity as they did not exhibit any haemolytic activity on erythrocytes or cytotoxic activity against mammalian primary cell lines. Finally, the NKL- MUT selectively triggers the killing of the melanoma cell line B16F10 by means of a pro-apoptotic pathway at a concentration range in which no effects were found in normal mammalian cell lines. In conclusion, the two peptides could be considered as promising candidates in the fight against antibiotic resistance and tumour proliferative action, and also be used as innovative adjuvants, either to decrease chemotherapy side effects or to enhance anticancer drug activity.


2023 - Journal article


Fish & shellfish immunology (Online) 142 (2023). doi:10.1016/j.fsi.2023.109099


Keywords: Antimicrobial peptides, NK-lysin, Enterococcus faecalis, Acinetobacter baumannii, Melanoma cells, Trematomus bernacchii, Marine biotechnologies


View the Product


CNR People


ExploRA

The research activities of the Institute are carried out in the context of research, development and innovation projects, both national and international, based on regional funding programs (POR FEAMPA - Regional Operational Program of the European Maritime Affairs Fisheries Fund and Aquaculture and POR FESR - Regional Operational Program of the European Regional Development Fund) or ministerial (PRIN - Projects of relevant national interest, PNRA - National Research Program in Antarctica, PO FEAMPA - National Operational Program European Maritime Affairs Fisheries and Aquaculture Fund) , programs for European Territorial Cooperation (Interreg), direct funding programs of the European Commission (Horizon2020 and Horizon Europe, Life, JPI - Joint Programming Initiatives, ERA-NET Cofund) and thematic collaboration initiatives managed by international organizations such as, for example , the FAO - GFCM (General Fisheries Commission for the Mediterranean). The Institute also develops funded projects in the context of collaborations with private companies in the sectors of the blue economy as well as technology transfer and research results. Research projects, mainly of a collaborative nature, are developed through a wide network of partners that include major Italian and foreign research institutions and universities.

FIND OUT MORE
error: Content is protected !!